BioAnalytiX Wins John & Mary Pappajohn Business Plan Award

FOR IMMEDIATE RELEASE

BioAnalytiX Among the Winners of the John & Mary Pappajohn Business Plan Awards

Thessaloniki, June 22, 2026 — BioAnalytiX, the Greek AI startup bringing advanced diagnostics to radiology, is proud to announce its recognition at the distinguished John & Mary Pappajohn Business Plan Awards, organized by the Entrepreneurship Hub at Anatolia College.

BioAnalytiX stood out among dozens of innovative proposals from across the Greek region, winning one of five major cash prizes of €4,000 along with access to a powerful business-support and mentoring network.

About the Competition

The competition bears the name of renowned Greek-American entrepreneur John Pappajohn and is organized by the Entrepreneurship Hub at Anatolia College — a leading innovation accelerator in Northern Greece. The jury evaluated each business plan across three key criteria:

• Innovation and Sustainability: The uniqueness of the company's approach to solving contemporary challenges.
• Growth Prospects: BioAnalytiX's potential to successfully enter and scale in international markets.
• Team and Expertise: The knowledge and passion of the founders to realize their vision.

What the Prize Means for BioAnalytiX

This award is an important validation of the hard work our team has put into building AI-powered medical imaging technology that matters. The recognition from a competition tied to the legacy of John Pappajohn — a figure synonymous with backing bold, transformative ideas — is deeply meaningful to us.

The €4,000 prize will be invested directly into advancing BioAnalytiX's technology and strengthening our market presence. Equally important, the mentoring and entrepreneurship network unlocked through the Entrepreneurship Hub at Anatolia College provides invaluable support as we prepare to scale.

Company Statement

“This award is a wonderful recognition of our team's hard work and an important boost for the future of BioAnalytiX. The support from the Entrepreneurship Hub at Anatolia College and the legacy of John Pappajohn give us the tools to accelerate our growth and take the next big step.”

— The BioAnalytiX Founding Team

About BioAnalytiX

Founded in March 2024 and headquartered in Thessaloniki, Greece, BioAnalytiX builds AI products for healthcare and education. Our flagship product, Orasis AI, is an AI-assisted platform that helps radiologists analyze brain CT scans faster and with greater accuracy, reducing time-to-diagnosis for critical conditions. Our second product, Gnosis AI, is an AI study companion for university students grounded in their official course material.

BioAnalytiX has previously been recognized in the Forbes Greece ‘30 Under 30’ list, won first place at Ennovation 2024 and YERAME 2024, and placed second at InnoHealth 2024. The company holds strategic partnerships with the General Hospital of Larissa and ACTA Lab.

Media Contact:

Email: info@bioanalytix.info

Website: https://bioanalytix.info

LinkedIn: https://www.linkedin.com/company/bioanalytixinc/